Literature DB >> 32371782

Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.

Omar Badri1, Chrysalyne D Schmults1, Pritesh S Karia1,2, Emily S Ruiz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32371782      PMCID： PMC7606517          DOI： 10.1097/DSS.0000000000002423

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   2.914


× No keyword cloud information.
  5 in total

1.  Recent trends in systemic psoriasis treatment costs.

Authors:  Vivianne Beyer; Stephen E Wolverton
Journal:  Arch Dermatol       Date:  2010-01

2.  Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.

Authors:  Renu George; Warren Weightman; Graeme R Russ; Kym M Bannister; Timothy H Mathew
Journal:  Australas J Dermatol       Date:  2002-11       Impact factor: 2.875

3.  Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin.

Authors:  D B McKenna; G M Murphy
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

4.  Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin.

Authors:  R G L de Sévaux; J V Smit; E M G J de Jong; P C M van de Kerkhof; A J Hoitsma
Journal:  J Am Acad Dermatol       Date:  2003-09       Impact factor: 11.527

5.  Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.

Authors:  J N Bavinck; L M Tieben; F J Van der Woude; A M Tegzess; J Hermans; J ter Schegget; B J Vermeer
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544
  5 in total
  1 in total

1.  Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Authors:  Zeeshaan-Ul Hasan; Ikhlaaq Ahmed; Rubeta N Matin; Victoria Homer; John T Lear; Ferina Ismail; Tristan Whitmarsh; Adele C Green; Jason Thomson; Alan Milligan; Sarah Hogan; Vanessa Van-de-Velde; Liza Mitchell-Worsford; Jonathan Kentley; Claire Gaunt; Yolande Jefferson-Hulme; Sarah J Bowden; Piers Gaunt; Keith Wheatley; Charlotte M Proby; Catherine A Harwood
Journal:  Br J Dermatol       Date:  2022-06-14       Impact factor: 11.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.